Clinical Trial Results

Showing: All studies [change]
Condition: Breast Cancer Location: Frederick, Maryland 25 trials found
New Search
Filter
Trial Phase
Study Type
National Mammography Database
N/AOBSERVATIONAL Reston, Virginia
RECRUITING
GammaPod Dose Escalation Radiation for Early Stage Breast Cancer
NAINTERVENTIONAL Baltimore, Maryland +3 more
RECRUITING
ROSETTA Breast-01: The Effects and Safety of Pumitamig in Patients With Triple-Negative Breast Cancer
PHASE3INTERVENTIONAL Springdale, Arkansas +4 more
RECRUITING
GammaPod Registry and Quality of Life Nomogram
N/AOBSERVATIONAL Bel Air, Maryland +3 more
RECRUITING
A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence
PHASE3INTERVENTIONAL Daphne, Alabama +4 more
RECRUITING
Study of Tucatinib and Doxil in Participants With Human Epidermal Growth Factor Receptor 2 Positive (HER2+) Metastatic Breast Cancer
PHASE2INTERVENTIONAL Columbia, Maryland +4 more
RECRUITING
A Phase III Study of Dato-DXd With or Without Durvalumab Compared With Investigator's Choice of Chemotherapy in Combination With Pembrolizumab in Patients With PD-L1 Positive Locally Recurrent Inoperable or Metastatic Triple-negative Breast Cancer (TROPION-Breast05)
PHASE3INTERVENTIONAL Daphne, Alabama +4 more
RECRUITING
T-DXd Based Therapy Followed by Endocrine Therapy Plus Dual HER2 Blockade in First-line HER2+/ HR+ Metastatic Breast Cancer and Retreatment With T-DXd
PHASE3INTERVENTIONAL Columbia, Maryland +4 more
RECRUITING
Prospective Study to Assess a Diagnostic Aid for Cancer
N/AOBSERVATIONAL Coronado, California +4 more
RECRUITING
Alpelisib/iNOS Inhibitor/Nab-paclitaxel in Patients With HER2 Negative Metaplastic Breast Cancer (MpBC)
PHASE2INTERVENTIONAL Bethesda, Maryland +2 more
RECRUITING
Administering Peripheral Blood Lymphocytes Transduced With a CD70-Binding Chimeric Antigen Receptor to People With CD70 Expressing Cancers
PHASE1, PHASE2INTERVENTIONAL Bethesda, Maryland
RECRUITING
Tumor Related Epilepsy
N/AOBSERVATIONAL Bethesda, Maryland
RECRUITING
Follow-Up Study of Subjects Previously Enrolled in Poxviral Vector Gene Transfer Studies
N/AOBSERVATIONAL Bethesda, Maryland
RECRUITING
Metarrestin (ML-246) in Subjects With Metastatic Solid Tumors
PHASE1INTERVENTIONAL Fairway, Kansas +1 more
RECRUITING
Genomic Services Research Program
N/AOBSERVATIONAL Bethesda, Maryland
RECRUITING
Phase 3 Study of Gedatolisib as First-Line Treatment for Patients With HR-Positive, HER2-Negative Advanced Breast Cancer (VIKTORIA-2)
PHASE3INTERVENTIONAL Jonesboro, Arkansas +4 more
RECRUITING
Collection of Blood From Patients With Cancer, Other Tumors, or Tumor Predisposition Syndromes for Genetic Analysis
N/AOBSERVATIONAL Bethesda, Maryland
RECRUITING
A Natural History Study of Metabolic Sizing in Health and Disease
N/AOBSERVATIONAL Bethesda, Maryland
RECRUITING
Evaluation of Late Effects and Natural History of Disease in Patients Treated With Radiotherapy
N/AOBSERVATIONAL Bethesda, Maryland
RECRUITING
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
N/AOBSERVATIONAL Birmingham, Alabama +4 more
RECRUITING
A Synthetic Lethality-Focused Algorithm to Identify Therapeutic Options in Advanced Metastatic Breast Cancer (SYNTHESIS-Breast)
NAINTERVENTIONAL Bethesda, Maryland
RECRUITING
000860: A Phase I/II Study of Zotiraciclib for Recurrent Malignant Gliomas With Isocitrate Dehydrogenase 1 or 2 (IDH1 or IDH2) Mutations
PHASE1, PHASE2INTERVENTIONAL Bethesda, Maryland
RECRUITING
Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial
PHASE2INTERVENTIONAL Birmingham, Alabama +4 more
RECRUITING
Administration of Autologous T-Cells Genetically Engineered to Express T-Cell Receptors Reactive Against Neoantigens in People With Metastatic Cancer
PHASE2INTERVENTIONAL Bethesda, Maryland
RECRUITING
Collection of Blood From Patients With Cancer
N/AOBSERVATIONAL Bethesda, Maryland
RECRUITING
Filter Trials
Trial Phase
Study Type